Results 111 to 120 of about 8,099 (196)

Sacral insufficiency fracture after stereotactic body radiation therapy for sacral metastasis

Clinical Case Reports, 2018
Key Clinical Message Stereotactic body radiation therapy (SBRT) allows the targeting of high doses of radiation with steep dose gradients. Vertebral fracture is increasingly recognized as an adverse event after SBRT; however, no sacral fractures have ...
Terufumi Kawamoto, Kei Ito, Tomohisa Furuya, Keisuke Sasai, Katsuyuki Karasawa   +4 more
doaj   +1 more source

Impact of Intraprostatic Simultaneous Integrated Boost on Long‐Term Outcomes in Unfavorable Intermediate‐Risk Prostate Cancer Treated With Dose‐Escalated Radiotherapy and Short‐Term Androgen Deprivation Therapy

The Prostate, Volume 86, Issue 8, Page 961-969, June 2026.
ABSTRACT Background Unfavorable intermediate‐risk prostate cancer (UIR‐PCa) represents a biologically heterogeneous subgroup with a higher risk of recurrence compared with favorable intermediate‐risk disease. Contemporary management frequently includes dose‐escalated radiotherapy (RT) combined with short‐term androgen deprivation therapy (ADT). Whether
Cem Onal, Aysenur Elmali, Birhan Demirhan, Ertugrul Senturk, Petek Erpolat, Ozan Cem Guler   +5 more
wiley   +1 more source

MRI-guided lung SBRT: Present and future developments [PDF]

, 2017
Stereotactic body radiotherapy (SBRT) is rapidly becoming an alternative to surgery for the treatment of early-stage non-small cell lung cancer patients.
Wetscherek, A, Martin F. Fast, Menten, Martin J, Fast, Martin F, Fast, MF, Martin J. Menten, Andreas Wetscherek, Wetscherek, Andreas, Menten, MJ   +8 more
core   +1 more source

Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma
Jacob T Hall,1 Andrew M Moon,2,3 Michael Young,1 Xianming Tan,3,4 Rami Darawsheh,5 Flora Danquah,3 Joel E Tepper,1,3 Ted K Yanagihara1,3 1Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill, NC, USA; 2Division of ...
Hall JT, Moon AM, Young M, Tan X, Darawsheh R, Danquah F, Tepper JE, Yanagihara TK   +7 more
doaj  

Intrahepatic Cholangiocarcinoma: Epidemiological Trends, Risk Factors, Diagnostic Challenges, and Advances in Personalized Therapy—A Comprehensive Review

Journal of Gastroenterology and Hepatology, Volume 41, Issue 6, Page 1701-1721, June 2026.
ABSTRACT Intrahepatic cholangiocarcinoma (iCCA) ranks as the second most common primary liver cancer, compared to about 20% of cases. Its global incidence has climbed over the past four decades, yet early detection remains indefinable due to its asymptomatic nature. Five‐year survival rate of approximately is under 10%.
Yaqoob Muhammad, YuZhu Jin, Kai Luo, He Bai, Xudong Zhang, Xu Sun, Zahoor Maheen, Ali Tanveer, Saeed Muddasar Muhammad, Jialin Qu, Guixin Zhang   +10 more
wiley   +1 more source

A Multi‐Institutional Retrospective Study of 21 Dogs Having Undergone Hypofractionated Radiotherapy for Adrenal Tumours (2017–2024)

Veterinary and Comparative Oncology, Volume 24, Issue 2, Page 229-239, June 2026.
ABSTRACT Radiation therapy (RT) has emerged as a promising non‐surgical approach for treating canine adrenal tumours. This multi‐institutional, retrospective study describes clinical outcomes for 21 dogs having been prescribed a course of hypofractionated image‐guided intensity‐modulated RT (IMRT) entailing delivery of 25–35 Gy total in 5 fractions ...
Yen‐Hao Erik Lai, Michael S. Kent, Michael W. Nolan, Dah‐Renn Fu, Jayme S. Looper   +4 more
wiley   +1 more source

The PACE trial: International randomised study of laparoscopic prostatectomy vs. stereotactic body radiotherapy (SBRT) and standard radiotherapy vs. SBRT for early stage organ-confined prostate cancer.

, 2018
TPS153 Background: The development of Stereotactic Body Radiotherapy (SBRT) has provided a further treatment option for early stage prostate cancer. In addition to the benefits of an overall treatment time reduction, profound hypofractionation could ...
Alison Tree, null null, Vincent Khoo, Nicholas John Van As, Kirsty Morrison   +4 more
core   +1 more source

The Role of Targeted Radiation Therapy in the Treatment of Renal Cell Carcinoma

Kidney Cancer
Over the past decade, innovations in radiation technology and technique have led to the increasing use of stereotactic body radiotherapy (SBRT) for the treatment of renal cell carcinoma.
Albert Lee, Karie D. Runcie, James B. Yu
doaj   +1 more source

Evaluation of response after SBRT for liver tumors

, 2017
International audienceStereotactic body radiotherapy (SBRT) has developed over the last few years for the treatment of primary and metastatic hepatic tumors.
Tetreau, Raphaël, Deshayes, Emmanuel, Riou, Olivier, Llacer, Carmen   +3 more
core   +1 more source

Efficacy and safety of stereotactic body radiotherapy for hepatocellular carcinoma with tumor thrombus in right atrium: a two-center retrospective review

Radiation Oncology
Background We sought to evaluate the efficacy and toxicity of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma with tumor thrombus in right atrium (RATT). Methods HCC patients with RATT treated with SBRT at two institutions between June
Yongjie Shui, Jia Yang, Xianzhi Zhao, Yang Yang, Chunshan Yu, Dongjun Dai, Liang Chen, Haiyan Chen, Di Chen, Xia Li, Lihong Liu, Qiaoying Tian, Yinglu Guo, Huojun Zhang, Qichun Wei   +14 more
doaj   +1 more source